GENE ONLINE|News &
Opinion
Blog

Licensing
Licensing Bispecific Antibody
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
Licensing China
LG Chem Lands Innovent As China Partner For Gout Candidate
2022-12-15
Licensing Clovis Oncology
Clovis Offloads Cancer Candidate to Novartis, Day After Declaring Bankruptcy
2022-12-13
Asia-Pacific Astellas Pharma
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Licensing Kite Pharma
Kite to Use Refuge’s Gene Expression Platform for New CAR-T Therapies
2022-10-21
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Licensing Novo Nordisk
Novo Nordisk Places $700 Million Bet on Ventus’ NLRP3 Inhibitor Program
2022-09-30
Licensing Cancer
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Trials & Approvals Hypercholesterolemia
AstraZeneca Blocks Ionis’ Hypercholesterolemia Treatment from Moving into a Phase 3 Study
2022-09-23
Licensing Gilead Sciences
Gilead Forking Over $280 million to Everest to Regain Rights to Breast Cancer Treatment
2022-08-16
Licensing GSK
GSK Puts Up $100 Million for Mersana’s HER2-Targeting ADC Candidate
2022-08-09
China Sanofi
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Licensing Sosei Heptares
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
Licensing Merck
Oncology Research Collaboration between Kelun-Biotech and MSD
2022-07-27
Licensing F-star
Takeda Throws $1 Million at F-star to Develop Bispecific Antibody For Novel Cancer Therapies
2022-07-21
1 2 3 4 … 7
LATEST
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top